The company has substantially advanced this progress of an innovative treatment for amyloid heart disease, utilizing Attruby. Early trial data reveals significant improvements for patients affected with a severe disease. The emphasis underscores BridgeBio's focus to treating significant patient needs in the cardiology arena. Attruby: Br… Read More